Core Viewpoint - The Yunnan Provincial Drug Administration conducted routine inspections of 45 pharmaceutical wholesale and retail chain headquarters, with all inspected companies meeting regulatory requirements except for two, which faced corrective actions [2][3]. Group 1: Inspection Results - 45 pharmaceutical companies were inspected, and all but two companies complied with the requirements [2][3]. - The inspections were conducted between March and May 2025, with specific dates for each company listed [2][3]. - Companies such as Yunnan Baiyao Group and Yunnan Hongxiang Traditional Chinese Medicine Technology Co., Ltd. were among those inspected and found compliant [2][3]. Group 2: Non-compliance and Actions Taken - Two companies, Kunming Taihe Pharmaceutical Co., Ltd. and Yunnan Medical Health Co., Ltd., were found non-compliant and faced corrective measures, including suspension of operations [2][3]. - The Yunnan Provincial Drug Administration is taking steps to address potential illegal activities associated with these companies [2][3].
云南省药品监督管理局关于药品批发（零售连锁总部）企业常规检查结果的通告（2025年 第24号）
Zhong Guo Zhi Liang Xin Wen Wang·2025-07-28 08:48